https://www.selleckchem.com/products/BIBW2992.html
ons of donation experiences based on unrelated donation may not provide best estimates of experience for this group).For patients with relapsed or refractory classical Hodgkin lymphoma (cHL), salvage chemotherapy followed by consolidation with autologous stem cell transplant (ASCT) remains the standard of care. Even with this aggressive treatment strategy, 5-year progression-free survival is ≤50%, and there remains interest in maintenance strategies to improve long-term disease-free survival. Lenalidomide is an immunomodulatory agent w
Like
Comment
Share
